Centre examines overpricing and non-availability of drugs
The Dollar Business Bureau The Union Ministry of Chemicals and Fertilizers, on Tuesday, informed that the Special Committee recommendations are being examined for formulating a ‘Policy for Promotion of Manufacturing of Bulk Drugs’. The Union Minister Ananth Kumar informed Lok Sabha that a special Committee, under the chairmanship of Secretary, Department of Health Research, has been constituted to check the issues pertaining to the Active Pharmaceutical Ingredients (API). The Committee will check the whole issues of APIs by identifying the APIs of critical importance and will then work out on a package of interventions and procedures to build domestic production capabilities and further examine the cost implications, the Minister added. The recommendations made by the Committee include the ...
Pharma Industry well prepared for NLEM 2015 & DPCO 2016: Expert
The Dollar Business “With NLEM (National List of Essential Medicine) 2015 and DPCO (Drug Price Control Order) 2016, more drugs are likely to come under price control but this will not affect the growth of the pharmaceutical industry. The growth trend will be much better as compared to the past,” said a highly placed source from the Organisation of Pharmaceutical Producers of India (OPPI). “In the past, the Pharmaceutical Industry was not well prepared to take the impact of NLEM 2011 and the subsequent DPCO 2013,” added the source. While NLEM is a list of medicines, prepared by the Ministry of Health and Family Welfare, which are essential in India, the DPCO is an order issued by the government under the essential commodities ...
